EUVIMEDEUVIMED entdecken
Crossref

3,4‐Dimethoxychalcone Protects Against Steroid Induced Femoral Head Necrosis by Suppressing Ferroptosis via Activation of STAT3 ‐Nrf2 Signaling Pathway

Li-Jiang Han, Jian-Sen Miao, Sheng-Huan Wu, Juan-Nan Zhan, Guang-Can Tan, Jian-Feng Yang, Lian-Wei Zhang, Zheng-Hao Wu, Le-Yang Liu, Ping Shang, Cheng-Long Xie iD, Hai-Xiao Liu iD

The FASEB Journal · 30.06.2026 · 40 (12)

DOI: 10.1096/fj.202600307r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 10.06.2026. Verfasst von Li-Jiang Han und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, NF-E2-Related Factor 2, Ferroptosis, Signal Transduction. Die Arbeit nennt 38 Literaturangaben. Gefördert von: | Medical and Health Research Project of Zhejiang Province (), Medical and Health Research Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucocorticoid‐induced osteonecrosis of the femoral head (GIONFH) is a frequently encountered complication in orthopedic practice, yet its precise pathogenic mechanisms remain incompletely understood. Dysregulation of bone metabolism induced by glucocorticoids (GCs) is considered a key contributing factor. 3,4‐Dimethoxychalcone (3,4DC), an organic compound, has shown potential biological activities, but its role in the context of GIONFH has not been elucidated. This study investigates the protective effects and underlying mechanisms of 3,4DC against dexamethasone (Dex)‐induced ferroptosis and its therapeutic potential in GIONFH.A rat model of GIONFH was established through intraperitoneal administration of Dex, and in vitro studies were performed by culturing osteoblasts (OBs) under Dex treatment conditions. To evaluate the effects of 3,4DC on Dex‐treated OBs, we employed C11‐BODIPY and FerroOrange staining, assessed mitochondrial function, and analyzed protein expression via Western blot and immunofluorescence. The impact of 3,4DC on the bone microarchitecture of the femoral head in rats was further examined using micro‐CT, H&E staining, as well as immunofluorescence and immunohistochemistry at both imaging and histological levels. Our results indicate that 3,4DC effectively inhibits Dex‐induced ferroptosis and attenuates the development of GIONFH. In vitro, 3,4DC treatment significantly increased glutathione (GSH) levels while reducing malondialdehyde (MDA) production, lipid peroxidation, and mitochondrial reactive oxygen species (ROS) accumulation. Furthermore, 3,4DC enhanced STAT3 phosphorylation, upregulated glutathione peroxidase 4 (GPX4) and osteogenesis‐related proteins, and promoted bone formation. Mechanistically, 3,4DC activated the STAT3/Nrf2 signaling pathway. Notably, silencing STAT3 with siRNA abrogated the protective effects of 3,4DC in Dex‐treated OBs.3,4DC alleviates GIONFH by activating the STAT3/Nrf2 signaling pathway, thereby suppressing ferroptosis and may have potential clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorNF-E2-Related Factor 2FerroptosisSignal TransductionChalconesFemur Head NecrosisAnimalsRatsRats, Sprague-DawleyMaleDexamethasoneOsteoblastsReactive Oxygen SpeciesGlucocorticoids

Stichwörter der Autor:innen

3,4‐dimethoxychalconeGIONFHSTAT3‐Nrf2 signaling pathwayferroptosisosteoblast

Substanzen

STAT3 Transcription FactorNF-E2-Related Factor 2ChalconesStat3 protein, ratNfe2l2 protein, ratDexamethasoneReactive Oxygen SpeciesGlucocorticoids

Autor:innen und Institutionen

  • Department of Orthopaedic, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
  • Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, China.
  • School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
  • Department of Rehabilitation, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.

ORCID-Profile: Cheng-Long Xie, Hai-Xiao Liu

Förderung

  • | Medical and Health Research Project of Zhejiang Province ()
  • Medical and Health Research Project of Zhejiang Province

Zitieren

APA

Han, L. J., Miao, J. S., Wu, S. H., Zhan, J. N., Tan, G. C., Yang, J. F., Zhang, L. W., Wu, Z. H., Liu, L. Y., Shang, P., Xie, C. L., & Liu, H. X. (2026). 3,4‐Dimethoxychalcone Protects Against Steroid Induced Femoral Head Necrosis by Suppressing Ferroptosis via Activation of STAT3 ‐Nrf2 Signaling Pathway. The FASEB Journal, 40(12). https://doi.org/10.1096/fj.202600307r

Vancouver

Han LJ, Miao JS, Wu SH, Zhan JN, Tan GC, Yang JF, et al. 3,4‐Dimethoxychalcone Protects Against Steroid Induced Femoral Head Necrosis by Suppressing Ferroptosis via Activation of STAT3 ‐Nrf2 Signaling Pathway. The FASEB Journal. 2026;40(12). doi:10.1096/fj.202600307r

BibTeX
@article{Han2026,
  author = {Han, Li-Jiang and Miao, Jian-Sen and Wu, Sheng-Huan and Zhan, Juan-Nan and Tan, Guang-Can and Yang, Jian-Feng and Zhang, Lian-Wei and Wu, Zheng-Hao and Liu, Le-Yang and Shang, Ping and Xie, Cheng-Long and Liu, Hai-Xiao},
  title = {3,4‐Dimethoxychalcone Protects Against Steroid Induced Femoral Head Necrosis by Suppressing Ferroptosis via Activation of STAT3 ‐Nrf2 Signaling Pathway},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {12},
  doi = {10.1096/fj.202600307r}
}
Kostenlos starten →